The U.S. Food and Drug Administration has granted pre-market approval to Mainstay Medical Holdings for the production of an implantable neurostimulator for chronic low back pain.
Rheumatoid arthritis is not a life threatening condition per se, but it can have a dramatic impact on life expectancy. As a chronic systemic inflammatory condition, rheumatoid arthritis increases the risk of a number of other leading causes of death. Are you familiar with mortality risk in RA? Take this quiz.
